Table 3 of
Sodi, Mol Vis 2012; 18:2736-2748. Table 3 of
Sodi, Mol Vis 2012; 18:2736-2748.
Table 3. Electrophysiological and molecular results of the VMD patients included in the study (families A-G). For each eye Arden ratio is indicated.
| Family | Family member | EOG OD | EOG OS | Allele1 | Allele2 |
|---|---|---|---|---|---|
| A | III-3 | 1.22 | 1.40 | p.Arg218Gly | WT |
| A | II-5 | 2.00 | 2.10 | WT | WT |
| A | II-4 | 1.40 | 1.45 | p.Arg218Gly | WT |
| A | III-4 | NA | NA | p.Arg218Gly | WT |
| A | II-3 | 1.47 | 1.42 | p.Arg218Gly | WT |
| A | III-1 | NA | NA | p.Arg218Gly | WT |
| A | III-2 | 2.15 | 1.95 | WT | WT |
| A | I-2 | NA | NA | p.Arg218Gly | WT |
| B | II-1 | 1.30 | 1.25 | p.Arg218Cys | WT |
| B | I-1 | 1.40 | 1.20 | p.Arg218Cys | WT |
| B | I-2 | 2.13 | 2.35 | WT | WT |
| C | II-1 | 1.35 | 1.25 | p.Arg25Trp | WT |
| C | I-1 | 1.32 | 1.11 | p.Arg25Trp | WT |
| C | I-2 | 2.45 | 2.30 | WT | WT |
| D | II-1 | 1.40 | 1.40 | p.Phe298Ser | WT |
| D | I-1 | 2.11 | 2.45 | WT | WT |
| D | I-2 | 1.35 | 1.25 | p.Phe298Ser) | WT |
| E | I-1 | 1.43 | 1.30 | p.Arg25Trp | WT |
| E | II-1 | NA | NA | p.Arg25Trp | WT |
| F | II-1 | 1.15 | 1.20 | PIle73Leu | WT |
| G | I-2 | 1.30 | 1.45 | p.Arg25Trp | WT |
| G | II-1 | 1.28 | 1.33 | p.Arg25Trp | WT |
| G | II-2 | 1.45 | 1.32 | p.Arg25Trp | WT |
| G | I-3 | 1.34 | 1.15 | p.Arg25Trp | WT |
| G | II-5 | 2.30 | 2.45 | WT | WT |